Xenotransplantation is inching closer to clinical reality at Columbia, where decades of work in immune tolerance are converging to make lifesaving pig-to-human organ transplants possible.
When a West Point graduate’s wife faced a rare, life-threatening cancer, it was a fellow alum—now a pioneering liver surgeon at Columbia—who stepped in to save her life.
Columbia has enrolled the first patient in a multicenter clinical trial investigating extracellular vesicle technology for the treatment of perianal fistulizing Crohn's Disease.
Columbia/NewYork-Presbyterian has once again been ranked among the nation’s best hospitals by the 2025-2026 U.S. News & World Report rankings, with top national recognition for surgical excellence across both adult and pediatric specialties.
Organ donation is not just a selfless act; it’s a rapidly evolving field shaped by science, ethics, and the quiet determination of people working to save lives in new and extraordinary ways.
Dr. Michel Sadelain, a pioneer of CAR T-cell therapy, is leading Columbia’s new initiative to expand the use of genetically engineered “living drugs” beyond cancer and into fields like autoimmunity and organ transplantation.
Looking for a heart surgeon? Learn how to find a top cardiac or cardiothoracic surgeon for valve disease, bypass, transplant, or minimally invasive surgery.
